Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

FDMTFDMT
15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in 4D MOLECULAR THERAPEUTICS IN

BANK OF AMERICA CORP /DE/ holds 1.1M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $14.9M as of 2026-Q2. The position was increased (+15.0% shares). FDMT represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$14.9M

Current Shares

1.1M

Total Value Change

+$13.2M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+15.0%
$14.9M0.0%$13.30
32
2026-Q1
Increased
974,173
+17.0%
$9.1M0.0%$8.46
32
2025-Q4
Increased
832,591
+1.6%
$6.2M0.0%$7.58
28
2025-Q3
Decreased
819,266
-8.7%
$7.1M0.0%$8.35
0
2025-Q2
Increased
897,070
+28.5%
$3.3M0.0%$3.84
33
2025-Q1
Increased
698,308
+81.4%
$2.3M0.0%$3.63
40
2024-Q4
Increased
384,880
+43.1%
$2.1M0.0%$5.30
35
2024-Q3
Increased
268,856
+18.1%
$2.9M0.0%$10.83
31
2024-Q2
Increased
227,599
+90.4%
$4.8M0.0%$20.99
42
2024-Q1
Decreased
119,557
-27.7%
$3.8M0.0%$31.86
0
2023-Q4
Increased
165,356
+20.2%
$3.4M0.0%$20.26
32
2023-Q3
Increased
137,530
+34.2%
$1.8M0.0%$12.73
33
2023-Q2
Decreased
102,508
-46.9%
$1.9M0.0%$17.73
0
2023-Q1
Increased
192,883
+149.2%
$3.3M0.0%$16.75
43
2022-Q4
First report
77,412
-
$1.7M0.0%$22.21
0

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used